ENTITY

Vaxcell-Bio Therapeutics (323990 KS)

Analysis

Health Care • South Korea

Vaxcell-Bio Therapeutics, Co. Ltd operates pharmaceutical development businesses. The Company develops anti-cancer drugs, cellular drugs, immune drugs, and other medicines. Vaxcell-Bio Therapeutics conducts businesses in South Korea.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00